StockNews.com upgraded shares of Surmodics (NASDAQ:SRDX – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Tuesday. Separately, Needham & Company LLC reissued a buy rating and set a $47.00 target price on shares of Surmodics in a research report on Wednesday, April 10th. View Our […]